Literature DB >> 31276887

Infliximab abrogates cadmium-induced testicular damage and spermiotoxicity via enhancement of steroidogenesis and suppression of inflammation and apoptosis mediators.

Raghda Habib1, Sara A Wahdan2, Amany M Gad3, Samar S Azab4.   

Abstract

Cadmium(Cd) is a serious environmental and occupational contaminant that represents a serious health hazard to humans and other animals. Reproductive health problems have been reported in men exposed to Cd. Testicular damage is one of the deleterious effects due to Cd exposure. Cd-induced testicular toxicity is mediated through oxidative stress, inflammation, testosterone inhibition and apoptosis. Thus, the present study was performed to assess the possible protective role of infliximab (IFX), anti-TNFα agent, against Cd-induced testicular damage and spermiotoxicity in rats. The rats were randomly allotted into six experimental groups: control, Cd sulphate treated, Cd sulphate treated with infliximab (5 mg/kg), Cd sulphate with infliximab (7 mg/kg), infliximab alone (5 mg/kg), and infliximab alone (7 mg/kg). The control group received saline. To induce testicular damage, Cd sulphate (1.5 mg/100 gm body weight/day) was dissolved in normal saline and orally administrated for 3 consecutive weeks. The rats in infliximab-treated groups were given a weekly dose of 5 mg/kg/week or 7 mg/kg/week of infliximab intraperitoneally. In the current study Cd exposure reduced sperm count, markers of testicular function, sperm motility as well as gene expression of testicular 3β-HSD and 17β-HSD and serum testosterone level. Additionally, it increased testicular oxidative stress, inflammatory and apoptotic markers. The histopathologic studies supported the biochemical findings. Treatment with infliximab significantly attenuated Cd-induced injury verified by the restoration of testicular architecture, enhancement of steroidogenesis, preservation of spermatogenesis, modulation of the inflammatory reaction along with suppression of oxidative stress and apoptosis. It was concluded that infliximab, through its antioxidant, anti-inflammatory and anti-apoptotic effects, represents a potential therapeutic option to protect the testicular tissue from the detrimental effects of Cd.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cadmium; Infliximab; Spermiotoxicity; Steroidogenesis; Testicular damage

Mesh:

Substances:

Year:  2019        PMID: 31276887     DOI: 10.1016/j.ecoenv.2019.109398

Source DB:  PubMed          Journal:  Ecotoxicol Environ Saf        ISSN: 0147-6513            Impact factor:   6.291


  10 in total

Review 1.  Infliximab Can Improve Traumatic Brain Injury by Suppressing the Tumor Necrosis Factor Alpha Pathway.

Authors:  Yiru Zhou; Ruihua Fan; Benson O A Botchway; Yong Zhang; Xuehong Liu
Journal:  Mol Neurobiol       Date:  2021-01-27       Impact factor: 5.590

2.  Effects of whole-life exposure to low-dose cadmium with post-weaning high-fat diet on offspring testes in a male mouse model.

Authors:  Lijuan Xiong; Bin Zhou; Jamie L Young; Jianxiang Xu; Kupper Wintergerst; Lu Cai
Journal:  Chem Biol Interact       Date:  2022-01-05       Impact factor: 5.192

3.  Evaluation of oxidative stress, inflammation, apoptosis, oxidative DNA damage and metalloproteinases in the lungs of rats treated with cadmium and carvacrol.

Authors:  Kerim Yesildag; Cihan Gur; Mustafa Ileriturk; Fatih Mehmet Kandemir
Journal:  Mol Biol Rep       Date:  2021-11-18       Impact factor: 2.316

4.  Role of inflammatory, oxidative, and ER stress signaling in the neuroprotective effect of atorvastatin against doxorubicin-induced cognitive impairment in rats.

Authors:  Noha M Mounier; Sara A Wahdan; Amany M Gad; Samar S Azab
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-03-23       Impact factor: 3.000

Review 5.  The endocrine disruptor cadmium: a new player in the pathophysiology of metabolic diseases.

Authors:  V M Bimonte; Z M Besharat; A Antonioni; V Cella; A Lenzi; E Ferretti; S Migliaccio
Journal:  J Endocrinol Invest       Date:  2021-01-26       Impact factor: 4.256

6.  Letrozole protects against cadmium-induced inhibition of spermatogenesis via LHCGR and Hsd3b6 to activate testosterone synthesis in mice.

Authors:  Yao Yao; Yangyang Wan; Xiaoyun Shi; Lan Guo; Hui Jiang; Xiansheng Zhang; Bo Xu; Juan Hua
Journal:  Reprod Biol Endocrinol       Date:  2022-03-02       Impact factor: 5.211

7.  Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis.

Authors:  Medhat Taha; Sara T Elazab; Alaa M Badawy; Abdullah A Saati; Naeem F Qusty; Abdullah G Al-Kushi; Anas Sarhan; Amira Osman; Amira E Farage
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-24

8.  Repositioning Linagliptin for the Mitigation of Cadmium-Induced Testicular Dysfunction in Rats: Targeting HMGB1/TLR4/NLRP3 Axis and Autophagy.

Authors:  Hany H Arab; Alzahraa A Elhemiely; Azza A K El-Sheikh; Hana J Al Khabbaz; El-Shaimaa A Arafa; Ahmed M Ashour; Ahmed M Kabel; Ahmed H Eid
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-11

9.  Differential Expression Profiles and Potential Intergenerational Functions of tRNA-Derived Small RNAs in Mice After Cadmium Exposure.

Authors:  Ling Zeng; Jinzhao Zhou; Yanwei Zhang; Xiaofei Wang; Mei Wang; Ping Su
Journal:  Front Cell Dev Biol       Date:  2022-01-03

Review 10.  Nutraceuticals: A New Challenge against Cadmium-Induced Testicular Injury.

Authors:  Herbert Ryan Marini; Antonio Micali; Giovanni Squadrito; Domenico Puzzolo; José Freni; Pietro Antonuccio; Letteria Minutoli
Journal:  Nutrients       Date:  2022-02-04       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.